It is a pharma private limited company based in Jaipur, Rajasthan, India, established in 2017.
2017 | Jaipur, Rajasthan, India | ActiveSeraphic Pharma Formulations Private Limited, a active private limited company, was established on 13 February 2017 in Jaipur, Rajasthan, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74999RJ2017PTC057181. Registered under ROC Roc Jaipur. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Amit Kumar Ganeriwal (Director), Pragati Ganeriwal (Director), Dinesh Kumar Biyani (Director). Past directors included Manoj Kumar Sharma, Savita Bansal. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at G-84 Tulip Enclave Vidhyadhar Nagar, Jaipur, Rajasthan, 302039.
U74999RJ2017PTC057181
057181
13 February 2017
₹0.10 M
₹0.10 M
Roc Jaipur
Unlisted
Active
Explore comprehensive insights into Seraphic Pharma Formulations Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Amit Kumar Ganeriwal | Director | 13 Feb 2017 | Current |
| Pragati Ganeriwal | Director | 13 Feb 2017 | Current |
| Dinesh Kumar Biyani | Director | 13 Feb 2017 | Current |
| Savita Bansal | Director | 01 Apr 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 23 Feb 2017 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Seraphic Pharma Formulations Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 37.52% decrease in profit. The company's net worth dipped by a decrease of 0.53%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Seraphic Pharma Formulations's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Seraphic Pharma Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Seraphic Pharma Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Seraphic Pharma Formulations's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Seraphic Pharma Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Seraphic Pharma Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Jaipur. was completed.
Savita Bansal was appointed as a Director was appointed as a Director on 01 Apr 2017 & has been associated with this company since 8 years 7 months . was recorded as a recent event.
Progress on Amit Kumar Ganeriwal was appointed as a Director was appointed as a Director on 13 Feb 2017 & has been associated with this company since 8 years 9 months . was documented.
The activity Pragati Ganeriwal was appointed as a Director was appointed as a Director on 13 Feb 2017 & has been associated with this company since 8 years 9 months . was completed.
Dinesh Kumar Biyani was appointed as a Director was appointed as a Director on 13 Feb 2017 & has been associated with this company since 8 years 9 months . was recorded as a recent event.
The CIN of Seraphic Pharma Formulations Private Limited is U74999RJ2017PTC057181.
Seraphic Pharma Formulations Private Limited is headquartered at G-84 Tulip Enclave Vidhyadhar Nagar, Jaipur, Rajasthan, 302039.
Seraphic Pharma Formulations Private Limited was incorporated on 13 February 2017.
The current directors of Seraphic Pharma Formulations Private Limited are
The primary industry of Seraphic Pharma Formulations Private Limited is Trade.
Seraphic Pharma Formulations Private Limited is unlisted.
The authorized capital of Seraphic Pharma Formulations Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Seraphic Pharma Formulations Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX